The Journal of Clinical Endocrinology & Metabolism · 2007 · 153 citations · 9 references
RTX treatment may induce sustained remission in patients with GD with low TRAb levels. However, RTX did not affect autoantibody levels and seems ineffective in patients with high TRAb levels. At present, high cost, low efficacy, and potential side effects do not support use in uncomplicated GD.
9
Paul Emery, Roy Fleischmann, Anna Filipowicz‐Sosnowska et al. · Arthritis & Rheumatism · 2006 · 1K citations
Mario Salvi, Guia Vannucchi, Irene Campi et al. · European Journal of Endocrinology · 2006 · 146 citations · Full text
Carlo Carella, Gherardo Mazziotti, F. Sorvillo et al. · Thyroid · 2006 · 117 citations